C5 Protein
Overview
Complement component 5 (C5) is a 188-kDa serum glycoprotein and a critical central hub of the complement cascade, one of the innate immune system's primary defense mechanisms. The C5 gene is located on chromosome 9q34.1 and encodes a protein synthesized primarily by the liver, though it can also be produced by immune cells including macrophages and dendritic cells. C5 functions as a structural and functional bridge between the early stages of complement activation (C1-C4) and the terminal lytic pathway, making it essential for both inflammatory signaling and pathogen elimination. Under normal physiological conditions, C5 circulates as an inactive zymogen in blood plasma at concentrations of approximately 80 μg/mL. When activated by upstream complement components during immune challenge, C5 undergoes proteolytic cleavage to generate C5a (an 11-kDa anaphylatoxin) and C5b (a 188-kDa fragment that nucleates the membrane attack complex).
Function/Biology
...C5 Protein
Overview
Complement component 5 (C5) is a 188-kDa serum glycoprotein and a critical central hub of the complement cascade, one of the innate immune system's primary defense mechanisms. The C5 gene is located on chromosome 9q34.1 and encodes a protein synthesized primarily by the liver, though it can also be produced by immune cells including macrophages and dendritic cells. C5 functions as a structural and functional bridge between the early stages of complement activation (C1-C4) and the terminal lytic pathway, making it essential for both inflammatory signaling and pathogen elimination. Under normal physiological conditions, C5 circulates as an inactive zymogen in blood plasma at concentrations of approximately 80 μg/mL. When activated by upstream complement components during immune challenge, C5 undergoes proteolytic cleavage to generate C5a (an 11-kDa anaphylatoxin) and C5b (a 188-kDa fragment that nucleates the membrane attack complex).
Function/Biology
C5 activation represents a critical decision point in the complement cascade where the pathway bifurcates into two distinct functional outcomes: C5a generation and membrane attack complex (MAC) formation. C5a is a potent anaphylatoxin that acts as a chemoattractant and inflammatory mediator, binding to the G-protein coupled receptor C5aR1 (CD88) and the atypical receptor C5L2 on immune cells to promote leukocyte recruitment, degranulation, and pro-inflammatory cytokine production. C5b, generated simultaneously from the same cleavage event, serves as the foundation for MAC assembly by sequentially recruiting complement components C6, C7, C8, and multiple C9 molecules to form a lytic pore in cell membranes.
The complement cascade can be activated through three distinct pathways: the classical pathway (triggered by antibody-antigen complexes), the alternative pathway (activated by microbial surfaces or damaged tissues), and the lectin pathway (initiated by mannose-binding lectin). Notably, C5 stands at the convergence point where all three pathways merge, meaning that regardless of initial activation trigger, C5 cleavage becomes the final common step toward terminal complement activation.
Role in Neurodegeneration
Excessive C5 activation has emerged as a significant contributor to neuroinflammation across multiple neurodegenerative conditions. In Alzheimer's disease, complement activation—particularly C5a and MAC formation—is observed around amyloid-β plaques and contributes to neuronal damage through both direct cytotoxic mechanisms and amplification of microglial activation. C5a signaling promotes the transition of microglia toward a pro-inflammatory phenotype, increasing release of TNF-α, IL-1β, and other cytokines that accelerate neuronal death. In Parkinson's disease, C5-mediated complement activation has been documented in substantia nigra autopsy samples from affected individuals, correlating with dopaminergic neuron loss and alpha-synuclein accumulation. Similarly, in amyotrophic lateral sclerosis (ALS), elevated C5a levels appear in cerebrospinal fluid, and experimental evidence suggests C5-MAC deposition on motor neurons facilitates their destruction. In multiple sclerosis-related neurodegeneration, complement-mediated demyelination involves C5-MAC formation on oligodendrocytes and axons. Huntington's disease studies indicate abnormal complement activation contributes to striatal neuronal vulnerability through C5a-mediated neuroinflammation.
Molecular Mechanisms
C5 cleavage is catalyzed by specialized proteases called C5 convertases. Classical and lectin pathway C5 convertases consist of C4b2a3b, while alternative pathway C5 convertases contain C3bBbC3b. These enzyme complexes cleave C5 between Arg747 and Ser748, releasing the soluble C5a fragment while exposing a reactive thioester bond in C5b that facilitates covalent attachment to nearby cell membranes or pathogens. In neurodegenerative contexts, complement activation is frequently dysregulated, with local production of C5a by activated glial cells amplifying inflammatory cycles. C5a binding to C5aR1 triggers Gαi-protein signaling and elevation of intracellular calcium, activating transcription factors like NF-κB that drive inflammatory gene expression. MAC formation creates osmotic stress through membrane perturbation, leading to cell lysis or triggering sublytic injury pathways including reactive oxygen species generation and caspase activation in neurons.
Clinical/Research Significance
Complement C5 inhibition has become a major therapeutic strategy in neurodegenerative diseases. The C5 convertase inhibitor pegcetacoplan and the C5a receptor antagonist iptacopan represent emerging treatments being investigated in neuroinflammatory conditions. Preclinical studies using C5-deficient mice or C5-blocking antibodies demonstrate reduced neuroinflammation and improved neuropathology in Alzheimer's and Parkinson's disease models. Human studies measuring C5a levels in cerebrospinal fluid are establishing C5 activation as a biomarker of active
See Also
- [CD19 Gene](/wiki/genes-cd19) — inhibits
- [CFB — Complement Factor B](/wiki/genes-cfb) — causes
- [CFB — Complement Factor B](/wiki/genes-cfb) — expressed_in
- [CLU — Clusterin (Apolipoprotein J)](/wiki/genes-clu) — causes
- [CR1 Gene — Complement Component 1q Receptor](/wiki/genes-cr1) — activates
- [CR1 Gene — Complement Component 1q Receptor](/wiki/genes-cr1) — co_discussed
- [CR1 Gene — Complement Component 1q Receptor](/wiki/genes-cr1) — expressed_in
- [CTSF Gene (CLN10)](/wiki/genes-ctsf) — causes
Pathway Diagram
The following diagram shows the key molecular relationships involving C5 Protein discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)